CVX-045

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCVX-045
Drug Alias NameCovX 045CVX-045PF-4856882
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionThrombospondin 1 agonists
TargetsThrombospondin 1
Therapy Area/IndicationsSolid tumoursCarcinomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncCovx Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A